Abstract:Background Aspirin, the most widely used nonsteroidal anti-inflammatory drug, damages the gastrointestinal tract. Interactions between Aspirin and gut microbiota have been reported. However, the impact of microbiome altered by Aspirin in intestinal homeostasis remains unclear. We aim to determine the roles of Aspirin-altered microbiota in intestinal injury. Methods Healthy volunteers (N=23) were administrated with Aspirin (100mg/day) for 30 days (IDDF2022-ABS-0097 Figure 1A. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Shotgun metagenomics analysis on paired fecal samples before (BA) and after Aspirin (AA) administration was performed. Mice were treated with Asprin and fecal samples were subjected to 16s-sequencing and metabolomics by gas chromatography coupled to time-of-flight mass spectrometry. Fecal Microbiome Transplantation (FMT) for mice were conducted and intestinal injury was assessed by Chiu’s grades. Cell proliferation and apoptosis were determined through Ki67 and TUNEL staining. Intestinal permeability was evaluated by FITC-labeled dextran. Results Partial least squares discriminant analysis and linear discriminant analysis showed differences in the gut microbiome profiles (IDDF2022-ABS-0097 Figure 1B-C. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). The abundance of Parabacteroide goldsteinii (P. goldsteinii) were found to be decreased in AA group (IDDF2022-ABS-0097 Figure 1 D-E. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Similar results were also found by 16s-sequencing in Aspirin-induced mice models (IDDF2022-ABS-0097 Figure 1F-G. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Scores of intestinal injury were negatively correlated with the abundance of P. goldsteinii (IDDF2022-ABS-0097 Figure 1H, J-M. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Intestinal concentrations of bile acids in mice were correlated with the abundance of P. goldsteinii (IDDF2022-ABS-0097 Figure 1I. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). More interestingly, FMT (IDDF2022-ABS-0097 Figure 1N. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis) from donating mice treated with Aspirin to NC mice induced intestinal injury, whereas FMT of NC mice to Aspirin-treated mice, helped intestinal repairment and decreased the intestinal injury score (IDDF2022-ABS-0097 Figure 1O-P. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Further, gavage of P. goldsteinii rescued Aspirin-induced intestinal injury (IDDF2022-ABS-0097 Figure 1Q-R. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis), promoted the proliferation of cells in crypts (IDDF2022-ABS-0097 Figure 1S-T. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis), decreased apoptosis (IDDF2022-ABS-0097 Figure 1U-V. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis) and preserved intestinal permeability (IDDF2022-ABS-0097 Figure 1W. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). These suggest that the Aspirin-suppressed microbiome, such as P. goldsteinii may be involved in the maintenance of intestinal homeostasis, which was disturbed by Aspirin treatment. Conclusions Aspirin leads to dysbiosis of gut microbiota, which impairs the homeostasis of the intestinal mucosa (IDDF2022-ABS-0097 Figure 1X. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Supplement of probiotics P. goldsteinii may be a promising strategy to prevent Aspirin-induced GI damage.

Aspirin ameliorates atherosclerotic immuno-inflammation through regulating the Treg/Th17 axis and CD39-CD73 adenosine signaling via remodeling the gut microbiota in ApoE-/- mice

Regulation on RhoA in Vascular Smooth Muscle Cells under Inflammatory Stimulation Proposes a Novel Mechanism Mediating the Multiple-Beneficial Action of Acetylsalicylic Acid

Both gut microbiota and cytokines act to atherosclerosis in ApoE -/- mice

Aspirin Prevent Colorectal Cancer Via <i>enterococcus Cecorum</i> -TIGIT <sup>+</sup>treg Cell Axis

Long-term Aspirin Intervention Can Inhibit TIGIT, Regulating T Cells to Reverse Damage to Intestines.

Metformin intervention ameliorates AS in ApoE-/- mice through restoring gut dysbiosis and anti-inflammation

Aspirin prevents colorectal cancer by regulating the abundance of Enterococcus cecorum and TIGIT+Treg cells

IDDF2019-ABS-0188 Gut Microbiota Modulates the Chemopreventive Efficacy of Aspirin on Colorectal Cancer Through Impact on Aspirin Bioavailability

IDDF2022-ABS-0097 Aspirin Impairs Intestinal Homeostasis Through Gut Microbiota-Bile-acids Axis

Aspirin Suppresses NFκB1 Expression and Inactivates Camp Signaling Pathway to Treat Atherosclerosis.

Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce Its Bioavailability and Chemopreventive Effects.

Aucubin ameliorates atherosclerosis by modulating tryptophan metabolism and inhibiting endothelial-mesenchymal transitions via gut microbiota regulation

Probiotic Enterococcus Faecium Attenuated Atherosclerosis by Improving SCFAs Associated with Gut Microbiota in ApoE-/- Mice

Paeonol reduces microbial metabolite α-hydroxyisobutyric acid to alleviate the ROS/TXNIP/NLRP3 pathway-mediated endothelial inflammation in atherosclerosis mice

β-sitosterol inhibits trimethylamine production by regulating the gut microbiota and attenuates atherosclerosis in ApoE–/– mice

Qing-Xin-Jie-Yu Granule alleviates atherosclerosis by reshaping gut microbiota and metabolic homeostasis of ApoE-/- mice

Effect of Shexiang Baoxin Pill on Inhibiting Atherosclerosis in ApoE-/- Mice by Reshaping Gut Microbiota and Fecal Metabolites

Aminoadipic acid aggravates atherosclerotic vascular inflammation through ROS/TXNIP/NLRP3 pathway, a harmful microbial metabolite reduced by paeonol

Gut Microbiota Composition Affects Procyanidin A2-Attenuated Atherosclerosis in ApoE-/- Mice by Modulating the Bioavailability of Its Microbial Metabolites

Effect of S-aspirin, a Novel Hydrogen-Sulfide-releasing Aspirin (ACS14), on Atherosclerosis in Apoe-Deficient Mice

Gut microbiota: a superior operator for dietary phytochemicals to improve atherosclerosis